Better Therapeutics, Inc. — Form D
Better Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-21. The offering totals $6.5M, of which $6.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-21
- Form: D
- Accession: 0001832415-23-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $6.5M
- Investors: 9
- Date of first sale: 2023-04-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-479714
Issuer
- Name: Better Therapeutics, Inc.
- CIK: 0001832415
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 548 MARKET ST. #49404, SAN FRANCISCO, CA, 94101
- Phone: 415-887-2311
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| MARK BERMAN | Executive Officer | NEW YORK, NY |
| Mark Heinen | Executive Officer | Chamblee, GA |
| David Perry | Director | Mount Pleasant, SC |
| David Perry | Executive Officer | Mount Pleasant, SC |
| Elder Granger | Director | Denver, CO |
| Richard Carmona | Director | San Francisco, CA |
| Risa Lavizzo-Mourey | Director | San Francisco, CA |
| Kristin Wynholds | Executive Officer | San Francisco, CA |
| Geoffrey Parker | Director | San Francisco, CA |
| Frank Karbe | Director | San Francisco, CA |
| Frank Karbe | Executive Officer | San Francisco, CA |
| Andrew Armanino | Director | San Francisco, CA |
Other filings by this issuer (2)
More